New drug trial aims to ease pouch disorder symptoms
NCT ID NCT06864403
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study tests whether mirikizumab can reduce symptoms of chronic pouch inflammation in 25 adults. Participants receive the drug every 4 weeks for a year and track their symptoms. The goal is to see if it helps control the condition without needing ongoing antibiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POUCHITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allegheny Health Network
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15212, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UCLA Vatche & Tamar Manoukian Division of Digestive Diseases
RECRUITINGLos Angeles, California, 90024, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of North Carolina
RECRUITINGChapel Hill, North Carolina, 27599-7080, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.